This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting neurological and psychiatric disorders, such as antidepressants and anxiolytics. Its structure, featuring a fluoro and methoxy substituent, allows for interactions with specific receptors in the brain, making it valuable in designing drugs with enhanced selectivity and efficacy. Additionally, it is explored in the development of radiopharmaceuticals for imaging and diagnostic purposes, leveraging its ability to bind to biological targets. Its application extends to organic synthesis, where it is used to create complex molecules for further pharmacological studies.